Cargando…
Autocrine effects of PCSK9 on cardiomyocytes
Proprotein convertase subtilisin kexin type 9 (PCSK9) is in the focus of cardiovascular research due to its role in hepatic low density lipoprotein (LDL) clearance. However, extrahepatic expression of PCSK9 such as in cardiomyocytes and its regulation by oxidized LDL (oxLDL) put notion on extrahepat...
Autores principales: | Wolf, Annemarie, Kutsche, Hanna Sarah, Schreckenberg, Rolf, Weber, Martin, Li, Ling, Rohrbach, Susanne, Schulz, Rainer, Schlüter, Klaus-Dieter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652747/ https://www.ncbi.nlm.nih.gov/pubmed/33169229 http://dx.doi.org/10.1007/s00395-020-00824-w |
Ejemplares similares
-
Oxidized low-density lipoprotein (oxLDL) affects load-free cell shortening of cardiomyocytes in a proprotein convertase subtilisin/kexin 9 (PCSK9)-dependent way
por: Schlüter, Klaus-Dieter, et al.
Publicado: (2017) -
Untypical Metabolic Adaptations in Spontaneously Hypertensive Rats to Free Running Wheel Activity Includes Uncoupling Protein-3 (UCP-3) and Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Expression
por: Wolf, Annemarie, et al.
Publicado: (2021) -
Induction of Proteasome Subunit Low Molecular Weight Protein (LMP)-2 Is Required to Induce Active Remodeling in Adult Rat Ventricular Cardiomyocytes
por: Petersen, Antonia, et al.
Publicado: (2020) -
Alterations in Glucose Metabolism During the Transition to Heart Failure: The Contribution of UCP-2
por: Kutsche, Hanna Sarah, et al.
Publicado: (2020) -
Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Deletion but Not Inhibition of Extracellular PCSK9 Reduces Infarct Sizes Ex Vivo but Not In Vivo
por: Schreckenberg, Rolf, et al.
Publicado: (2022)